Nasdaq-listed Altamira Therapeutics has successfully navigated a strategic repositioning with the assistance of legal counsel from Walder Wyss. The innovative move involved the sale of a 51% stake in its subsidiary, Altamira Medica, to a Swiss
Tags :Erik Lanz
Walder Wyss advises WEG as Swiss counsel in the USD 400 million acquisition of the industrial electric motors and generators business of the Regal Rexnord Corporation, a global manufacturer of electromechanical equipment. The transaction encompasses the
Under the legal guidance of Bär & Karrer and Walder Wyss, Gebrüder Meier and UIKER Antriebstechnik (UIKER) have come together to enhance their expertise in drive technology within the Swiss market through collaborative
Nexoya, a startup in Switzerland that focuses on marketing analytics, has closed a successful Series A funding round of USD5 million. The round was led by BlackSheep MadTech Fund and included investments from ZKB and
As we have informed here, Inflexion and Gyrus Capital have entered into an agreement for Inflexion to acquire a majority stake in dss+, a leading provider of operations management consulting services with a purpose of
TX Group and its subsidiary Goldbach have signed a binding agreement for the acquisition of Clear Channel Holding Switzerland, a driver for innovation in the Out-of-Home (OOH) advertising business, from Clear Channel International Limited. Goldbach
Livit, a leading Swiss real estate management company belonging to the Swiss Life Group, has sold its subsidiary Livit FM Services to ISS Switzerland. All 670 employees of Livit FM Services will be taken over by
DPE Deutsche Private Equity, a renowed growth investor in the DACH region, has successful closed the named DPE Continuation Fund I with a fund size of EUR 708 million. The transaction represents the largest German GP-led
Westhive, providers of flexible office space, successfully closes its Series A financing round raising CHF 6.3 million. The round is co-led by the Fairway Family Office and Redstone powered MA Ventures, the corporate venture capital fund
Private equity firm Astrog has entered into a binding agreement with privately owned industrial group International Chemical Investors Group (“ICIG”) whereby Astorg will acquire CordenPharma, a global pharmaceutical CDMO (Contract Development & Manufacturing Organisation) with
